2x Valuation Gap: BIO vs. CRL — Who’s Wrong?

Life Science

If the AI Trade Unwinds, What’s Actually the Best Safe Haven?

Cryptocurrency, Precious Metals, Technology

Walmart’s First Nuclear PPA: What It Signals About Corporate Energy’s Future

Consumer Goods, Energy

U.S. Unveils $17.5 Billion Nuclear Loan Package — and Cameco Stands to Win Big

Energy, Energy Metals

Energy Fuels to Buy Vacuumschmelze for $1.9 Billion, Creating Western Rare Earth Magnet Giant

Mining

Everyone’s Selling Tech, Should You Be Buying Microsoft?

Technology

Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk

Life Science

These Two TSX Stocks Are in a Valuation Dip Ahead of Recovery

Real Estate, Technology

Bitcoin Stabilizes Above $60,000 as Investors Weigh Entry Timing

Cryptocurrency, Technology

Google and Amazon Officially Launch AI Chip Counterattack, Nvidia’s Dominance Faces Major Test

Consumer Goods, Technology

Qualcomm Makes Another Move in AI Chess Game with $4 Billion Bet on Modular

Technology

How Much Power Do AI Data Centers Need? Enough for Chevron to Build Microsoft a Dedicated Power Plant

Energy, Technology

The White House Sets a Five-Year Goal, U.S. Quantum Technology R&D Enters the Fast Track

Financial Service, Technology

US ETF Inflows Hit Record Pace, AI Computing Power Thematic Funds Emerge as New Favorites

Financial Service, Technology

Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee

Life Science